Which has higher valuation and earnings, GH or NTRA?

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Guardant Health $982.02M 17.15 -$416.28M -$3.39 N/A Natera $2.31B 13.16 -$208.16M -$1.63 N/A

Is GH or NTRA more profitable?

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity. Company Net Margins Return on Equity Return on Assets Guardant Health -40.10% N/A -26.42% Natera -9.05% -14.74% -10.27%

Does the media favor GH or NTRA?

In the previous week, Natera had 14 more articles in the media than Guardant Health. MarketBeat recorded 27 mentions for Natera and 13 mentions for Guardant Health. Natera's average media sentiment score of 1.11 beat Guardant Health's score of 0.28 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Natera 16 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BTSG or GH?

In the previous week, Guardant Health had 8 more articles in the media than BrightSpring Health Services. MarketBeat recorded 13 mentions for Guardant Health and 5 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.15 beat Guardant Health's score of 0.28 indicating that BrightSpring Health Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BrightSpring Health Services 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor GH or FMS?

In the previous week, Guardant Health had 10 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 13 mentions for Guardant Health and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Guardant Health's average media sentiment score of 0.28 beat Fresenius Medical Care AG & Co. KGaA's score of -0.04 indicating that Guardant Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Fresenius Medical Care AG & Co. KGaA 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CELC or GH?

In the previous week, Celcuity had 6 more articles in the media than Guardant Health. MarketBeat recorded 19 mentions for Celcuity and 13 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.28 beat Celcuity's score of -0.13 indicating that Guardant Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Celcuity 2 Very Positive mention(s) 3 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 4 Very Negative mention(s) Neutral Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer HIMS or GH?

In the previous week, Hims & Hers Health had 10 more articles in the media than Guardant Health. MarketBeat recorded 23 mentions for Hims & Hers Health and 13 mentions for Guardant Health. Hims & Hers Health's average media sentiment score of 0.84 beat Guardant Health's score of 0.28 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 7 Very Positive mention(s) 8 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Guardant Health (GH) Competitors

$127.03 -3.14 (-2.41%)

Closing price 04:00 PM Eastern

Extended Trading

$127.11 +0.08 (+0.06%)

As of 07:48 PM Eastern

Compare

GH vs. NTRA, BTSG, FMS, CELC, and HIMS

Should you buy Guardant Health stock or one of its competitors? MarketBeat compares Guardant Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Guardant Health include Natera (NTRA), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Celcuity (CELC), and Hims & Hers Health (HIMS). These companies are all part of the "healthcare" industry.

How does Guardant Health compare to Natera?

Guardant Health (NASDAQ:GH) and Natera (NASDAQ:NTRA) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, risk, profitability, earnings, valuation and dividends.

Natera has a net margin of -9.05% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Natera's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Natera	-9.05%	-14.74%	-10.27%

Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	17.15	-$416.28M	-$3.39	N/A
Natera	$2.31B	13.16	-$208.16M	-$1.63	N/A

92.6% of Guardant Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 5.1% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Guardant Health has a beta of 1.61, indicating that its stock price is 61% more volatile than the broader market. Comparatively, Natera has a beta of 1.56, indicating that its stock price is 56% more volatile than the broader market.

Guardant Health currently has a consensus price target of $136.37, indicating a potential upside of 7.35%. Natera has a consensus price target of $256.81, indicating a potential upside of 21.22%. Given Natera's higher probable upside, analysts plainly believe Natera is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.95
Natera	1 Sell rating(s)	3 Hold rating(s)	14 Buy rating(s)	2 Strong Buy rating(s)	2.85

In the previous week, Natera had 14 more articles in the media than Guardant Health. MarketBeat recorded 27 mentions for Natera and 13 mentions for Guardant Health. Natera's average media sentiment score of 1.11 beat Guardant Health's score of 0.28 indicating that Natera is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Natera	16 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Natera beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Guardant Health compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, dividends, risk, media sentiment, profitability, analyst recommendations and institutional ownership.

BrightSpring Health Services has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, suggesting that its stock price is 61% more volatile than the broader market.

92.6% of Guardant Health shares are owned by institutional investors. 2.8% of BrightSpring Health Services shares are owned by insiders. Comparatively, 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Guardant Health had 8 more articles in the media than BrightSpring Health Services. MarketBeat recorded 13 mentions for Guardant Health and 5 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.15 beat Guardant Health's score of 0.28 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

BrightSpring Health Services presently has a consensus price target of $57.64, suggesting a potential downside of 5.32%. Guardant Health has a consensus price target of $136.37, suggesting a potential upside of 7.35%. Given Guardant Health's higher probable upside, analysts plainly believe Guardant Health is more favorable than BrightSpring Health Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.95

BrightSpring Health Services has a net margin of 2.27% compared to Guardant Health's net margin of -40.10%. BrightSpring Health Services' return on equity of 14.63% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.27%	14.63%	4.41%
Guardant Health	-40.10%	N/A	-26.42%

BrightSpring Health Services has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$12.91B	0.91	$190.67M	$1.41	43.18
Guardant Health	$982.02M	17.15	-$416.28M	-$3.39	N/A

Summary

BrightSpring Health Services beats Guardant Health on 11 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Guardant Health (NASDAQ:GH) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, risk, institutional ownership, valuation, media sentiment, dividends, analyst recommendations and earnings.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Guardant Health's net margin of -40.10%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-40.10%	N/A	-26.42%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Guardant Health has a beta of 1.61, indicating that its share price is 61% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, indicating that its share price is 20% less volatile than the broader market.

Guardant Health currently has a consensus target price of $136.37, indicating a potential upside of 7.35%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 34.00%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.95
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

In the previous week, Guardant Health had 10 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 13 mentions for Guardant Health and 3 mentions for Fresenius Medical Care AG & Co. KGaA. Guardant Health's average media sentiment score of 0.28 beat Fresenius Medical Care AG & Co. KGaA's score of -0.04 indicating that Guardant Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Fresenius Medical Care AG & Co. KGaA	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	17.15	-$416.28M	-$3.39	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.51	$1.11B	$1.90	11.00

Summary

Guardant Health beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Guardant Health compare to Celcuity?

Celcuity (NASDAQ:CELC) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

Celcuity has a beta of 0.1, suggesting that its stock price is 90% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, suggesting that its stock price is 61% more volatile than the broader market.

In the previous week, Celcuity had 6 more articles in the media than Guardant Health. MarketBeat recorded 19 mentions for Celcuity and 13 mentions for Guardant Health. Guardant Health's average media sentiment score of 0.28 beat Celcuity's score of -0.13 indicating that Guardant Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Celcuity	2 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	4 Very Negative mention(s)	Neutral
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Celcuity currently has a consensus price target of $152.09, suggesting a potential upside of 70.98%. Guardant Health has a consensus price target of $136.37, suggesting a potential upside of 7.35%. Given Celcuity's higher possible upside, equities research analysts plainly believe Celcuity is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Celcuity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.83
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.95

Celcuity has a net margin of 0.00% compared to Guardant Health's net margin of -40.10%. Guardant Health's return on equity of 0.00% beat Celcuity's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Celcuity	N/A	-244.61%	-50.22%
Guardant Health	-40.10%	N/A	-26.42%

Celcuity has higher earnings, but lower revenue than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Celcuity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Celcuity	N/A	N/A	-$177.04M	-$3.90	N/A
Guardant Health	$982.02M	17.15	-$416.28M	-$3.39	N/A

63.3% of Celcuity shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Comparatively, 5.6% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Guardant Health beats Celcuity on 10 of the 16 factors compared between the two stocks.

How does Guardant Health compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

Hims & Hers Health has a beta of 2.37, meaning that its stock price is 137% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, meaning that its stock price is 61% more volatile than the broader market.

Hims & Hers Health has higher revenue and earnings than Guardant Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.71	$128.37M	-$0.09	N/A
Guardant Health	$982.02M	17.15	-$416.28M	-$3.39	N/A

Hims & Hers Health has a net margin of -0.56% compared to Guardant Health's net margin of -40.10%. Hims & Hers Health's return on equity of 6.10% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Guardant Health	-40.10%	N/A	-26.42%

Hims & Hers Health presently has a consensus target price of $28.70, indicating a potential upside of 4.40%. Guardant Health has a consensus target price of $136.37, indicating a potential upside of 7.35%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts plainly believe Guardant Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	11 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.12
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	19 Buy rating(s)	1 Strong Buy rating(s)	2.95

In the previous week, Hims & Hers Health had 10 more articles in the media than Guardant Health. MarketBeat recorded 23 mentions for Hims & Hers Health and 13 mentions for Guardant Health. Hims & Hers Health's average media sentiment score of 0.84 beat Guardant Health's score of 0.28 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	7 Very Positive mention(s)	8 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Hims & Hers Health beats Guardant Health on 10 of the 17 factors compared between the two stocks.

Get Guardant Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

GH vs. The Competition

Export

Metric	Guardant Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$17.26B	$3.24B	$6.47B	$12.54B
Dividend Yield	N/A	2.38%	2.69%	5.22%
P/E Ratio	-37.47	17.78	22.39	24.18
Price / Sales	17.15	315.63	520.79	112.26
Price / Cash	N/A	111.64	41.34	57.13
Price / Book	-160.80	6.63	9.84	6.72
Net Income	-$416.28M	$24.20M	$3.57B	$337.19M
7 Day Performance	-0.38%	-3.24%	-1.16%	0.48%
1 Month Performance	45.01%	0.53%	3.85%	5.07%
1 Year Performance	177.42%	47.24%	27.40%	34.25%

Guardant Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
GH Guardant Health	1.9473 of 5 stars	$127.03 -2.4%	$136.37 +7.4%	+209.2%	$17.26B	$982.02M	N/A	2,506	Analyst Upgrade
NTRA Natera	4.3095 of 5 stars	$218.81 -2.0%	$256.60 +17.3%	+32.6%	$31.99B	$2.31B	N/A	6,140	Positive News Analyst Upgrade Insider Trade
BTSG BrightSpring Health Services	4.2751 of 5 stars	$59.98 -2.8%	$57.00 -5.0%	+148.0%	$11.96B	$12.91B	42.54	23,500	Positive News Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.6621 of 5 stars	$21.05 -2.4%	$28.00 +33.0%	-28.7%	$11.65B	$19.36B	11.08	1,488
CELC Celcuity	3.1103 of 5 stars	$122.96 -7.5%	$150.27 +22.2%	+686.7%	$6.48B	N/A	N/A	40	Trending News Analyst Forecast Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:GH) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Guardant Health (GH) Competitors

GH vs. NTRA, BTSG, FMS, CELC, and HIMS

How does Guardant Health compare to Natera?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Guardant Health compare to Celcuity?

Summary

How does Guardant Health compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Guardant Health (GH) Competitors

GH vs. NTRA, BTSG, FMS, CELC, and HIMS

How does Guardant Health compare to Natera?

Is GH or NTRA more profitable?

Which has higher valuation and earnings, GH or NTRA?

Do insiders & institutionals have more ownership in GH or NTRA?

Which has more volatility and risk, GH or NTRA?

Do analysts recommend GH or NTRA?

Does the media favor GH or NTRA?

Summary

How does Guardant Health compare to BrightSpring Health Services?

Which has more volatility and risk, BTSG or GH?

Do institutionals & insiders hold more shares of BTSG or GH?

Does the media favor BTSG or GH?

Do analysts recommend BTSG or GH?

Is BTSG or GH more profitable?

Which has stronger earnings and valuation, BTSG or GH?

Summary

How does Guardant Health compare to Fresenius Medical Care AG & Co. KGaA?

Do institutionals and insiders believe in GH or FMS?

Is GH or FMS more profitable?

Which has more volatility and risk, GH or FMS?

Do analysts rate GH or FMS?

Does the media favor GH or FMS?

Which has higher earnings and valuation, GH or FMS?

Summary

How does Guardant Health compare to Celcuity?

Which has more volatility and risk, CELC or GH?

Does the media refer more to CELC or GH?

Do analysts rate CELC or GH?

Is CELC or GH more profitable?

Which has higher valuation and earnings, CELC or GH?

Do insiders & institutionals hold more shares of CELC or GH?

Summary

How does Guardant Health compare to Hims & Hers Health?

Which has more risk and volatility, HIMS or GH?

Which has preferable earnings & valuation, HIMS or GH?

Is HIMS or GH more profitable?

Do analysts recommend HIMS or GH?

Does the media prefer HIMS or GH?

Do institutionals & insiders believe in HIMS or GH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

GH vs. The Competition

Guardant Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools